论文部分内容阅读
目的:探讨血清降钙素原在医院内获得性肺炎疗效评估中的价值。方法:选取我院2015年1月-2016年6月收治的患有医院内获得性肺炎的84例患者,将其随机分为两组,对照组给予常规抗感染治疗,观察组给予在血清降钙素原的监测下进行抗感染治疗。结果:观察组患者的抗生素使用疗程、住院时间、住院费用、细菌耐药率相比于对照组患者来说较为优越,存在显著差异(P<0.05),有统计学意义;观察组中PCT检测的特异性和敏感性较高,分别为100.0%和95.24%。结论:医院内获得性肺炎的治疗中加入血清降钙素原后疗效显著,具有一定的指导作用,可对抗菌治疗进行指导。
Objective: To investigate the value of serum procalcitonin in evaluating the curative effect of hospital acquired pneumonia. Methods: Eighty-four patients with nosocomial pneumonia admitted in our hospital from January 2015 to June 2016 were randomly divided into two groups. The control group was given conventional anti-infective therapy. The observation group was given serum Anti-infective therapy was performed under the monitoring of procalcitonin. Results: The duration of antibiotic treatment, length of stay, cost of hospitalization and rate of bacterial resistance in the observation group were superior to those in the control group (P <0.05), and there was significant difference between the two groups in the PCT test The specificity and sensitivity were higher, 100.0% and 95.24% respectively. Conclusions: The addition of serum procalcitonin to the treatment of intra-hospital acquired pneumonia has significant curative effect and can guide the antimicrobial therapy.